References
- Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-78 https://doi.org/10.1016/j.ehj.2004.09.014
- Therrien J, Dore A, Gersony W, Iserin L, Liberthson R, Meijboom F, et al. CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I. Can J Cardiol 2001;17:940-59
- Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol 2001;38:2035-42 https://doi.org/10.1016/S0735-1097(01)01635-7
- Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839-46 https://doi.org/10.1056/NEJM199903183401103
- Driscoll D, Allen HD, Atkins DL, Brenner J, Dunnigan A, Franklin W, et al. Guidelines for evaluation and management of common congenital cardiac problems in infants, children, and adolescents. A statement for healthcare professionals from the Committee on Congenital Cardiac Defects of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;90:2180-8 https://doi.org/10.1161/01.CIR.90.4.2180
- Schwerzmann M, Zafar M, McLaughlin PR, Chamberlain DW, Webb G, Granton J. Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy. Int J Cardiol 2006;110:104-7 https://doi.org/10.1016/j.ijcard.2005.05.062
- Holzer R, Cao QL, Hijazi ZM. Closure of a moderately large atrial septal defect with a self-fabricated fenestrated Amplatzer septal occluder in an 85-year-old patient with reduced diastolic elasticity of the left ventricle. Catheter Cardiovasc Interv 2005;64:513-8 https://doi.org/10.1002/ccd.20315
- Bruch L, Winkelmann A, Sonntag S, Scherf F, Rux S, Grad MO, et al. Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and/or right heart failure. J Interv Cardiol 2008;21:44-9 https://doi.org/10.1111/j.1540-8183.2007.00324.x
- Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol 2008;129:163-71 https://doi.org/10.1016/j.ijcard.2008.02.004
- Thanopoulos BD, Tsaousis GS, Djukic M, Al Hakim F, Eleftherakis NG, Simeunovic SD. Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder. Heart 2002;87:260-3 https://doi.org/10.1136/heart.87.3.260
- Yan C, Zhao S, Jiang S, Xu Z, Huang L, Zheng H, et al. Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart 2007;93:514-8 https://doi.org/10.1136/hrt.2006.091215
- Balint OH, Samman A, Haberer K, Tobe L, McLaughlin P, Siu SC, et al. Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart 2008;94:1189-93 https://doi.org/10.1136/hrt.2006.114660
- Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537 https://doi.org/10.1093/eurheartj/ehp297
- Pershukov VV, Pataraia SA, Batyraliev TA, Niiazova-Karben ZA, Sidorenko BA, Preobrazhenskii DV. Recommendations of the Working Group of European Society of Cardiology on diagnosis and treatment of pulmonary arterial hypertension. Kardiologiia 2005;45:84-91
- Rabasseda X. New research and new guidelines in cardiovascular therapy: a report from the European Society of Cardiology Congress 2007. Timely Top Med Cardiovasc Dis 2007;11:E25
- Schannwell CM, Steiner S, Strauer BE. Diagnostics in pulmonary hypertension. J Physiol Pharmacol 2007;58:591-602
- Marie Valente A, Rhodes JF. Current indications and contraindications for transcatheter atrial septal defect and patent foramen ovale device closure. Am Heart J 2007;153:81-4 https://doi.org/10.1016/j.ahj.2007.01.011
- Allcock RJ, O'Sullivan JJ, Corris PA. Atrial septostomy for pulmonary arterial hypertension. Heart 2003;89:1344-7 https://doi.org/10.1136/heart.89.11.1344
- Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114:1645-53 https://doi.org/10.1161/CIRCULATIONAHA.105.592055
- Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-65 https://doi.org/10.1056/NEJMra035488
- McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273-7 https://doi.org/10.1056/NEJM199801293380501
- Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet 2002;360:895-900 https://doi.org/10.1016/S0140-6736(02)11024-5
- Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-50 https://doi.org/10.1161/CIRCULATIONAHA.105.592386
- Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation 1999;99:1858-65
- Heath D, Helmholz HF Jr, Burchell HB, Dushane JW, Edwards JE. Graded pulmonary vascular changes and hemodynamic findings in cases of atrial and ventricular septal defect and patent ductus arteriosus. Circulation 1958;18:1155-66
- Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978;58:1107-22
- Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47
- Heath D, Helmholz HF Jr, Burchell HB, Dushane JW, Kirklin JW, Edwards JE. Relation between structural change in the small pulmonary arteries and the immediate reversibility of pulmonary hypertension following closure of ventricular and atrial septal defects. Circulation 1958;18:1167-74
- Beyer J. Atrial septal defect: acute left heart failure after surgical closure. Ann Thorac Surg 1978;25:36-43 https://doi.org/10.1016/S0003-4975(10)63484-4
- Ghosh S, Chatterjee S, Black E, Firmin RK. Surgical closure of atrial septal defects in adults: effect of age at operation on outcome. Heart 2002;88:485-7 https://doi.org/10.1136/heart.88.5.485